Journal of Drug Issues
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q4 | 26.2% | 0.575 | Q2 | 66.1% |
| 2024 | 1.2 | Q4 | 26.7% | 0.500 | Q2 | 62.2% |
| 2023 | 1.2 | Q4 | 18.5% | 0.478 | Q2 | 63.4% |
| 2022 | 1.7 | Q4 | 26.0% | 0.457 | Q2 | 63.5% |
| 2021 | 1.7 | Q4 | 34.0% | 0.428 | Q2 | 62.4% |
| 2020 | — | — | 0.359 | Q3 | 56.1% | |
| 2019 | — | — | 0.469 | Q2 | 65.6% | |
| 2018 | — | — | 0.593 | Q2 | 70.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1945-1369
ISSN
0022-0426
country
UScoverage
1971-2026